140 related articles for article (PubMed ID: 36830789)
1. The Relationship between the Expression of GATA4 and GATA6 with the Clinical Characteristics and Prognosis of Resectable Pancreatic Adenocarcinoma.
Heredia-Soto V; Gutiérrez-Sainz L; Ghanem I; Guerra L; Palacios E; de Uribe M; Trilla-Fuertes L; de Miguel M; Cejas P; Medina L; Calderón JM; Viñal D; Mendiola M; Feliu J
Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830789
[TBL] [Abstract][Full Text] [Related]
2. GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma.
de Andrés MP; Jackson RJ; Felipe I; Zagorac S; Pilarsky C; Schlitter AM; Martinez de Villareal J; Jang GH; Costello E; Gallinger S; Ghaneh P; Greenhalf W; Knösel T; Palmer DH; Ruemmele P; Weichert W; Buechler M; Hackert T; Neoptolemos JP; Notta F; Malats N; Martinelli P; Real FX
Gut; 2023 Mar; 72(3):535-548. PubMed ID: 36109153
[TBL] [Abstract][Full Text] [Related]
3. GATA6 identifies an immune-enriched phenotype linked to favorable outcomes in patients with pancreatic cancer undergoing upfront surgery.
van Eijck CWF; Real FX; Malats N; Vadgama D; van den Bosch TPP; Doukas M; van Eijck CHJ; Mustafa DAM;
Cell Rep Med; 2024 May; 5(5):101557. PubMed ID: 38733987
[TBL] [Abstract][Full Text] [Related]
4. EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of
Patil S; Steuber B; Kopp W; Kari V; Urbach L; Wang X; Küffer S; Bohnenberger H; Spyropoulou D; Zhang Z; Versemann L; Bösherz MS; Brunner M; Gaedcke J; Ströbel P; Zhang JS; Neesse A; Ellenrieder V; Singh SK; Johnsen SA; Hessmann E
Cancer Res; 2020 Nov; 80(21):4620-4632. PubMed ID: 32907838
[TBL] [Abstract][Full Text] [Related]
5. The value of GATA6 immunohistochemistry and computer-assisted diagnosis to predict clinical outcome in advanced pancreatic cancer.
Duan K; Jang GH; Grant RC; Wilson JM; Notta F; O'Kane GM; Knox JJ; Gallinger S; Fischer S
Sci Rep; 2021 Jul; 11(1):14951. PubMed ID: 34294813
[TBL] [Abstract][Full Text] [Related]
6. Gata6 is an important regulator of mouse pancreas development.
Decker K; Goldman DC; Grasch CL; Sussel L
Dev Biol; 2006 Oct; 298(2):415-29. PubMed ID: 16887115
[TBL] [Abstract][Full Text] [Related]
7. GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer.
O'Kane GM; Grünwald BT; Jang GH; Masoomian M; Picardo S; Grant RC; Denroche RE; Zhang A; Wang Y; Lam B; Krzyzanowski PM; Lungu IM; Bartlett JMS; Peralta M; Vyas F; Khokha R; Biagi J; Chadwick D; Ramotar S; Hutchinson S; Dodd A; Wilson JM; Notta F; Zogopoulos G; Gallinger S; Knox JJ; Fischer SE
Clin Cancer Res; 2020 Sep; 26(18):4901-4910. PubMed ID: 32156747
[TBL] [Abstract][Full Text] [Related]
8. Pancreas-specific deletion of mouse Gata4 and Gata6 causes pancreatic agenesis.
Xuan S; Borok MJ; Decker KJ; Battle MA; Duncan SA; Hale MA; Macdonald RJ; Sussel L
J Clin Invest; 2012 Oct; 122(10):3516-28. PubMed ID: 23006325
[TBL] [Abstract][Full Text] [Related]
9. Association between
Greendyk JD; Allen WE; Alexander HR; Beninato T; Eskander MF; Grandhi MS; Kennedy TJ; Langan RC; Maggi JC; De S; Court CM; Ecker BL
Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002058
[TBL] [Abstract][Full Text] [Related]
10. A GATA6-centred gene regulatory network involving HNFs and ΔNp63 controls plasticity and immune escape in pancreatic cancer.
Kloesch B; Ionasz V; Paliwal S; Hruschka N; Martinez de Villarreal J; Öllinger R; Mueller S; Dienes HP; Schindl M; Gruber ES; Stift J; Herndler-Brandstetter D; Lomberk GA; Seidler B; Saur D; Rad R; Urrutia RA; Real FX; Martinelli P
Gut; 2022 Apr; 71(4):766-777. PubMed ID: 33846140
[TBL] [Abstract][Full Text] [Related]
11. GATA4 and GATA6 control mouse pancreas organogenesis.
Carrasco M; Delgado I; Soria B; Martín F; Rojas A
J Clin Invest; 2012 Oct; 122(10):3504-15. PubMed ID: 23006330
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of GATA4 and GATA6 in the heart of rats with nitrofen-induced diaphragmatic hernia.
Takayasu H; Sato H; Sugimoto K; Puri P
J Pediatr Surg; 2008 Feb; 43(2):362-6. PubMed ID: 18280291
[TBL] [Abstract][Full Text] [Related]
13. GATA4 and GATA6 regulate pancreatic endoderm identity through inhibition of hedgehog signaling.
Xuan S; Sussel L
Development; 2016 Mar; 143(5):780-6. PubMed ID: 26932670
[TBL] [Abstract][Full Text] [Related]
14. GATA depletion impacts insulin-like growth factor 1 mRNA and protein levels in luteinizing porcine granulosa cells.
LaVoie HA; Kordus RJ; Nguyen JB; Barth JL; Hui YY
Biol Reprod; 2010 Dec; 83(6):1015-26. PubMed ID: 20739664
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the GATA Transcription Factor Family and Exploration of Their Relevance to Immune Infiltration and Tumor Microenvironment in Pancreatic Cancer.
Xu J; Cheng K; Lin H; Han W; He T; Nie X; Sun Y; Qiuman S; Reheman Y; Chen Q
Int J Gen Med; 2021; 14():9083-9101. PubMed ID: 34876843
[TBL] [Abstract][Full Text] [Related]
16. Unique functions of Gata4 in mouse liver induction and heart development.
Borok MJ; Papaioannou VE; Sussel L
Dev Biol; 2016 Feb; 410(2):213-222. PubMed ID: 26687508
[TBL] [Abstract][Full Text] [Related]
17. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
18. GATA6-positive lung adenocarcinomas are associated with invasive mucinous adenocarcinoma morphology, hepatocyte nuclear factor 4α expression, and KRAS mutations.
Nakajima N; Yoshizawa A; Nakajima T; Hirata M; Furuhata A; Sumiyoshi S; Rokutan-Kurata M; Sonobe M; Menju T; Miyamoto E; Chen-Yoshikawa TF; Date H; Haga H
Histopathology; 2018 Jul; 73(1):38-48. PubMed ID: 29469192
[TBL] [Abstract][Full Text] [Related]
19. GATA4 and GATA6 regulate intestinal epithelial cytodifferentiation during development.
Walker EM; Thompson CA; Battle MA
Dev Biol; 2014 Aug; 392(2):283-94. PubMed ID: 24929016
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the developing small intestine in the absence of either GATA4 or GATA6.
Walker EM; Thompson CA; Kohlnhofer BM; Faber ML; Battle MA
BMC Res Notes; 2014 Dec; 7():902. PubMed ID: 25495347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
